Patent Application
20220088367
The embodiments herein generally relate to heart compression and assist and arrhythmia control devices. More particularly, the disclosure relates to a smart cardiac assist device.
Congestive Heart failure is a condition in which the heart doesn't pump blood as well as it should. A global study has revealed that India leads in deaths from heart failure. The International Congestive Heart Failure (INTER-CHF) conducted a study aimed at measuring mortality across a year in patients who had suffered a heart attack. The results revealed that 23% Indian heart patients who were part of this study did not survive, whereas only 7% of Chinese succumbed. South East Asian countries showed 15% mortality, while both South America and Middle East had 9% fatalities. Heart failure affects nearly 6 million Americans.
In conditions that over work heart include high blood pressure, valve disease, thyroid disease, kidney disease, diabetes or heart defects present at birth.
In the medical profession, it is recognized that it is necessary, in the event of a cardiac arrest to assist the heart in its pumping action until effective spontaneous cardiac contraction can restore normal blood circulation. During cardiac arrest, the pumping action of the heart ceases and the blood flow stops. If the blood flow or circulation is not re-instituted either by restoration of spontaneous cardiac activity or by some other provision of artificial circulatory support; irreversible vital organ damage and clinical death will ensue.
Such patients with moderate to severe cardiac failure may be less/non-responsive to the conventional medical management. The presently existing Ventricular Assist devices commercially available are more invasive. These devices have lot of complications related to its blood handling properties, un-natural blood flow patterns which affect the end-organs and these devices damage the native heart due to the need to incise heart to install the device.
Therefore, there is a need for a smart cardiac assist device designed to assist the weak muscles of a failing heart that augments the heart's pumping power and its installation is least invasive. This device could also incorporate pacemaker and de-fibrillator technology to help patients suffering from electrical dysfunctions as bradycardia or tachyarrhythmia
Some of the objects of the present disclosure are described herein below:
The main objective of the present disclosure is to provide a smart cardiac assist device to help increase performance of the heart.
Another objective of the present disclosure is to provide a smart cardiac assist device which helps in leading a near normal function of the diseased heart.
Still another objective of the present disclosure is to provide less invasive approach to treat moderate to severe cardiac failures.
Yet another objective of the present disclosure is to provide more physiological functional assistance to the heart.
Another objective of the present disclosure is to help understand and control heart function in real time.
Another objective of the present disclosure is to provide demand based functional assistance.
Another objective of the present disclosure is to provide pacemaker assistance to the weak heart.
Another objective of the present disclosure is to provide defibrillation assistance to the heart.
Another objective of the present disclosure is to provide data related to blood flow dynamics, cardiac anatomy etc.
The other objectives and advantages of the present disclosure will be apparent from the following description when read in conjunction with the accompanying drawings, which are incorporated for illustration of preferred embodiments of the present disclosure and are not intended to limit the scope thereof.
In view of the foregoing, an embodiment herein provides a smart cardiac assist device which may aid in ventricular recovery. The device proactively assists the left and right ventricular chambers to contract and relax better.
According to an embodiment, the disclosure comprises an implantable and less invasive device to help increase performance of the heart, leading to near normal function of the diseased heart.
According to an embodiment, the device is configured to be installed around the heart in hospital setting, wherein it would form an enclosure to the native patient heart and will assist the left and right ventricular chambers to contract and relax better to help the diseased heart to recover.
According to an embodiment, the device may have capability of self analyzing and suggesting the treatment option for conditions like fibrillation or diminishing electrical signal in the heart. The device may also have a defibrillation and a pacemaker option to treat the heart in case of emergencies.
These and other aspects of the embodiments herein will be better appreciated and understood when considered in conjunction with the following description and the accompanying drawings. It should be understood, however, that the following descriptions, while indicating preferred embodiments and numerous specific details thereof, are given by way of illustration and not of limitation. Many changes and modifications may be made within the scope of the embodiments herein without departing from the spirit thereof, and the embodiments herein include all such modifications.
The detailed description is set forth with reference to the accompanying figures. In the figures, the left-most digit(s) of a reference number identifies the figure in which the reference number first appears. The use of the same reference numbers in different figures indicates similar or identical items.
The embodiments herein and the various features and advantageous details thereof are explained more fully with reference to the non-limiting embodiments and detailed in the following description. Descriptions of well-known components and processing techniques are omitted so as to not unnecessarily obscure the embodiments herein. The examples used herein are intended merely to facilitate an understanding of ways in which the embodiments herein may be practiced and to further enable those of skill in the art to practice the embodiments herein. Accordingly, the examples should not be construed as limiting the scope of the embodiments herein.
As mentioned above, there is a need to develop a device for aid during critical conditions to help in ventricular recovering of the heart. The embodiments herein achieve this by providing a smart cardiac assist device to be called as iEnclose, which is configured to help increase performance of the heart, leading to the near normal function of the diseased heart.
In an embodiment, the device 101 is installed around the heart in a minimal invasive and less complicated way, eliminating the chances of damage to the native heart. Referring now to the drawings, and more particularly to
In an embodiment, the plurality of sensors includes conduction sensors 102, chemical sensors 104 and pressure sensors 106. The plurality of sensors are provided for measuring parameters of the heart, wherein the parameters include conduction of electrical impulse, lactate levels, glucose levels, regional saturation of Oxygen (SO2), Regional Carbon di Oxide (CO2) saturation (SCO2), Ischaemic markers like Troponin, Right Atrial Saturations, Left Atrial Saturations, blood pressure from aorta, pulmonary artery, right atrium, left atrium, right ventricle and left ventricle. The conduction sensors 102 measure the conduction of electrical impulse in micro volts. The chemical sensors 104 measure lactate levels, glucose levels, regional saturation of Oxygen (SO2), Regional Carbon di Oxide (CO2) saturation (SCO2), Ischaemic markers like Troponin, Right Atrial Saturations, Left Atrial Saturations. The pressure sensors 106 measure blood pressure from aorta, pulmonary artery, right atrium, left atrium, right ventricle and left ventricle. The measured values from the conduction sensors 102, chemical sensors 104 and pressure sensors 106 are transmitted to the processor.
The filaments are Electro active polymers (EAP) including a plurality of sensors and plurality of actuators. The plurality of electro active polymer (EAP) sensors detects the contraction and relaxation of the heart. The detected signals from the plurality of EAP sensors are transmitted to the plurality of actuators for contracting. There are two types of filaments, contractile filaments and energy generating filaments. Contractile filaments contract and relax in accordance to the cardiac cycle through the electrical signals of the heart. Energy generating filaments contract and relax along with the contractile filaments and generate power and consume energy during the ventricular activity. Energy generating filaments are Electro Active Polymer (EAP) filaments. The Electro Active Polymer (EAP) filaments generate power on stretching, wherein the generated power is stored in capacitors and then transferred to battery. The power stored in the battery will be reused to contract the actuators present in the Electro Active Polymer (EAP) filaments and power the EAP sensors to function accordingly. The filaments can be controlled using various ways. In a first way, controllers are connected physically to the skin for communicating with a subcutaneously placed receiver. The receiver is connected to a processor for transmitting the signal and controlling the filaments. In another way, the filaments can be controlled using a mobile device communicating to the device 101 wirelessly. The filaments can also include a computer connected to the device 101 wirelessly.
The plurality of electrodes includes pacing electrode 108 and defibrillation electrode 110. The pacing electrode 108 and the defibrillation electrode 110 are provided for pacing the heart of a patient. The plurality of electrodes is provided for treating patients suffering from electrical dysfunction such as bradycardia or tachyarrhythmia or conduction defects. The pacing electrode 108 and the defibrillation electrode 110 can be activated automatically or manually based on the need of the cardiac electrical activity. The device 101 also includes ultrasound electrodes for measuring blood flow dynamics and cardiac anatomy.
The device 101 can control the diastolic filling of the heart to prevent over filling and hence over-distension of the heart muscle during cardiac cycle. The Electro Active Polymer sensor filaments of the device 101 are attached to the epicardium for detecting the stretch of the cardiac muscle. On detecting abnormal dilatation of the heart compared to standard dilatation of the heart, the Electro Active Polymer sensor filaments transmit a signal to the processor for activating the actuator.
The power and signal conduction membrane 112 detects a stretch of the the EAP sensor filament which generate power and transmit a signal to the processor to act accordingly. The neutral membrane 114 is present next to the power and signal conduction membrane 112 separating a device 101 of left ventricle from device 101 of right ventricle.
In an embodiment, the device 101 includes an internal battery 125 and internal processor. The battery and processor 125 are inserted in the device 101 placed around the heart. The internal battery 125 powers the device 101 and the internal processor 125 controls the device 101. A subcutaneous charging pad 122 having an external battery 123 is attached to the device 101 through a wire. The subcutaneous charging pad 122 placed away from the device 101, under the skin charges the internal battery 125 of the device 101. The charging pad 122 includes an internal pad. In an embodiment, the charging pad 122 is an induction pad.
In an embodiment, a charger 127 is provided for charging. The charger 127 includes a memory card 126 and a smart chip 128. The smart chip 128 is a SIM card like communication and identification unit, for retrieving data and instructing the device 101 remotely. The smart chip 128 is remotely connected to a cloud, through wireless network. The smart chip 128 receives data from internal pad in the charging pad 122 and transmits data to internal pad in the charging pad 122. The internal pad is a main communication interface between the charging pad 122 used for transferring power to the batteries, calibrating the device 101, and processing commands received from an external controller placed outside the skin. In an embodiment, the data includes measured values of parameters of the heart from the conduction sensors 102, chemical sensors 104 and the pressure sensors 106.
The data received by the smart chip 128 is saved in the memory card 126. The cloud can be accessed through an app provided along with the device 101. In an embodiment, the data from the smart chip of the device 101 can be retrieved in a wired and/or wireless mode. The data can be retrieved intermittently or may be displayed continuously on an external device monitor connected to the cloud. The external or/and internal data storage units may store the data of continuous and intermittent events of the device.
In an embodiment, functions of the device 101 can be controlled in wired, wireless and automatic mode. The device 101 can be controlled wirelessly using software or an app provided with the device 101. In the wired mode the device 101 is controlled from an external computer or mobile device. In the wireless mode the device 101 is controlled from an external mobile device in Short Range Control or Long Range control. In the automatic mode the device 101 automatically understands the ECG signal using the plurality of sensors and functions accordingly.
The device 101 includes internal power storage unit. The internal power storage unit includes battery 125. The internal power storage units can be charged by multiple mechanisms. The multiple mechanisms include recycling unit, internal power generator and external source.
In an embodiment, the recycling unit mechanism consists of energy generated by the energy generating electro active polymer filaments. The recycling unit mechanism may include any other conventional self energy generating unit. In an embodiment, the device 101 produces power from energy generating electro active polymer filaments and the produced power is used for charging the internal battery 125. Hence, the device 101 requires little external power supply.
In an embodiment, the internal power generator mechanism generates power using thermoelectric technology. Thermo-electric generation is harvesting and recovering heat which is converted into electrical energy using thermoelectric generators (TEG).
In an embodiment, the external source mechanism for charging the internal storage unit includes using an induction pad 122 inserted below the skin and an external magnetic induction device. The external source can also include an external backup battery/mains electrical source 127.
In an embodiment, the device 101 is equipped with artificial intelligence for customizing the functions of the device 101 based on a patient's everyday activity and helping in power management.
In an embodiment, the external power storage battery 123 is charged using external power source 127 for recharging the battery and is used as a backup for conditions needing additional power requirements and emergencies.
The mesh layer 201 is made up of a bio-compatible material. In an embodiment, the bio-compatible layer is polyurethane. The bio-compatible materials prevents inflammatory reactions and rejection related issues due to insertion of the device 101 around the heart and helps the device 101 to function normally for longer periods.
The filaments layer 202 includes the electro active polymer (EAP) filaments, the plurality of actuators 118 and the plurality of EAP sensors 116.
The electrode and sensors layer 203 includes the plurality of electrodes and the plurality of sensors. The plurality of electrodes includes pacing electrode 108 and defibrillation electrode 110, the plurality of sensors includes the conduction sensors 102, chemical sensors 104, and the pressure sensors 106.
The glue layer 204 connects and attaches all the layers including the mesh layer 201, the filaments layer 202 and the electrode and sensors layer 203 together.
The device 101 is installed around the heart using the deployment tool 301. The deployment tool includes the screw 302 and the hand grip 306. Material for the hand grip 306 is rubber or metal. The device 101 is folded for inserting using the deployment tool 301. The folded device 101 is held using threads 304 attached to the mesh. The threaded screw hole 120 of the device 101 mates with the screw 302 of the deployment tool 301. The folded device 101 is inserted around the heart through left thoracotomy or midline sternotomy using the deployment tool 301. The incision is made as small as possible, but adequate for visualizing fixation markings and confirming the proper placement of the device 101 on the surface of the heart. Diagnostic tools like ultrasound Echocardiography and or fluoroscopy can be used for helping in positioning the device 101 and checking the proper placement of the device 101 around the heart. The device 101 helps in recovery of the heart, helps in decision making, helps other conventional assist devices, helps in heart transplant. The device 101 can be used as a destination therapy. The device 101 forms an enclosure to the heart of the patient and assists the left and right ventricular chambers of the heart to contract and relax better, helping the diseased heart to recover. In an embodiment, stem cell therapy on heart muscle can be used in conjunction with this device 101 to help regenerate a healthy cardiac tissue in the place of dead/dying tissue.
In an embodiment, the device 101 includes sensors 401 for measuring cardiac muscle strength, native cardiac contraction, blood pressure (from aorta, pulmonary artery, right atrium, left atrium, right ventricle, left ventricle), cardiac electrical signals, regional oxygenation saturation, regional carbon dioxide saturation, regional lactate measurement and cardiac output monitoring (Left Ventricle outflow/aortic flow and right ventricle outflow/pulmonary flow). The sensors 401 are pressure sensors placed on Right Atrium, Pulmonary Artery, Left Atrium, and Aorta.
A main advantage of the present disclosure is that the device provides less invasive approach to treat moderate-severe cardiac failure—causing minimal to no damage to the existing heart muscle, hence providing more time for the impaired cardiac tissue to recover.
Another advantage of the present disclosure is that the device provides more physiological functional assistance by keeping the pulsatile waveforms for better perfusion of body tissues and organs.
Still another advantage of the present disclosure is that the device provides more parameters measured directly from the heart, helping to understand and control heart function in real time.
Yet another advantage of the present disclosure is that the device provides better understanding of the native cardiac function and keeping a track of its recovery/failure.
Another advantage of the present disclosure is that the device provides demand based functional assistance to help the heart to return to its normal function; also it may help provide adequate functional assistance to the heart in various physical activities done by the patient. Hence helping the patient to live near to normal healthy lifestyle.
Another advantage of the present disclosure is that the device has self generating power recycling units helping in less dependency to external power supply and hence prolonging battery life.
Another advantage of the present disclosure is that the device provides wireless retrieval of the device and heart function data.
Another advantage of the present disclosure is that the device has pacemaker and de-fibrillator integrated.
Another advantage of the present disclosure is that the device provides cardiac muscle stretch data and performs regional oxygen and carbon dioxide saturation monitoring of cardiac muscle.
Another advantage of the present disclosure is that the device provides more safety and freedom to the patient due to almost self-dependent control of the device and may send regular updates to the patient and physician on device function and cardiac status.
Another advantage of the present disclosure is that there is possibility of measuring blood flow dynamics and cardiac anatomy directly from the device, whose results may be seen on a wired or wireless device monitor.
Another advantage of the present disclosure is that the device provides wireless remote data visualization or control, using a SIM card like unit.
Another advantage of the present disclosure is that there may be an internal processing unit in the device to learn and adapt to patient physiological conditions.
Another advantage of the present disclosure is that there may be an artificial intelligence driven device function present.
The foregoing description of the specific embodiments will so fully reveal the general nature of the embodiments herein that others can, by applying current knowledge, readily modify and/or adapt for various applications such specific embodiments without departing from the generic concept, and, therefore, such adaptations and modifications should and are intended to be comprehended within the meaning and range of equivalents of the disclosed embodiments. It is to be understood that the phraseology or terminology employed herein is for the purpose of description and not of limitation. Therefore, while the embodiments herein have been described in terms of preferred embodiments, those skilled in the art will recognize that the embodiments herein can be practiced with modification within the spirit and scope of the embodiments as described herein.
All references, including publications, patent applications, and patents cited herein are hereby incorporated by reference to the same extent as if each reference were individually and specifically indicated to be incorporated by reference and were set forth in its entirety herein.
The use of the terms “a” and “an” and “the” and similar referents in the context of describing the invention (especially in the context of the following claims) is to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. The terms “comprising,” “having,” “including,” and “containing” are to be construed as open-ended terms (i.e., meaning “including, but not limited to,”) unless otherwise noted. Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.
Preferred embodiments of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Variations of those preferred embodiments may become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventors expect skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than as specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.
| Number | Date | Country | Kind |
|---|---|---|---|
| 201941021108 | May 2019 | IN | national |
This patent application is a continuation of International Application No. PCT/IB2020/054730, filed on May 19, 2020, which claims the benefit of priority to Indian Patent Application No. 201941021108, filed May 28, 2019, the entire teachings and disclosures of both applications are incorporated herein by reference thereto.
| Number | Date | Country | |
|---|---|---|---|
| Parent | PCT/IB2020/054730 | May 2020 | US |
| Child | 17535163 | US |
